Skip to main content
. Author manuscript; available in PMC: 2021 Jan 5.
Published in final edited form as: Int J Pharm. 2019 Nov 23;573:118894. doi: 10.1016/j.ijpharm.2019.118894

Figure 5.

Figure 5.

Cellular uptake of FAM-siRNA complexes under hypoxia conditions at 4 hr (A) and the representative FAM-siRNA complexes at different time points (1, 2, and 4 hr) (B) in MP-38 cells determined using flow cytometry. The relative mean fluorescence (MFI) is the fold change compared to the no complexes or siRNA treated group. A commercial agent DharmaFECT 1 (DF) was studied as a control. Statistical analysis comparing the developed complexes to the DF group at the same time point. * p<0.05; *** p<0.001.